2012 Archives

 Sanofi Pasteur Canada receives Health Canada Approval of Menactra® Meningococcal Conjugate Vaccine Indication for Infants starting at 9 months  ...
Canada-wide campaign launched to find curious, talented youth! After 19 years of competition, the Sanofi BioGENEius Challenge Canada (SBCC)...
This October, thousands of Canadian Muslims will be embarking on one of the greatest religious observances in Islam, the Hajj and Umrah. Requiring...
  Grade 12 researcher wins top honours in Sanofi BioGENEius Challenge Canada finals at National Research Council, Ottawa OTTAWA, May 8 -- An Ontario...
Toronto – April 23, 2012 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY) has invested $1.3 million in a “condensing...
Toronto, Canada - February 28, 2012 – Mark Lievonen, President of Sanofi Pasteur Limited, wishes to congratulate players of the Langley British...
Sanofi Pasteur is the first vaccine manufacturer in the world to roll out innovative GS1 bar codes on commercially available vaccine products...